Selected research
Market Structure
Global Botanical and Herbal Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Botanical and Herbal Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Botanical and Herbal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Botanical and Herbal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Botanical and Herbal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Botanical and Herbal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Botanical and Herbal Drug include China TCM, Yunnan Baiyao, Tong Ren Tang, Kwangdong, Guangzhou Baiyunshan Pharmaceutical, Weleda, Tsumura, Tasly Holding Group and Taiji, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Botanical and Herbal Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Botanical and Herbal Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Botanical and Herbal Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Botanical and Herbal Drug market size, projected growth trends, production technologies, key applications, and end-use industries.
Botanical and Herbal Drug Segment by Company
China TCM
Yunnan Baiyao
Tong Ren Tang
Kwangdong
Guangzhou Baiyunshan Pharmaceutical
Weleda
Tsumura
Tasly Holding Group
Taiji
Schwabe
Jumpcan Pharmaceutical
Huarun 999
GW Pharmaceuticals
Buchang Pharmaceuticals
Bionorica Se
Botanical and Herbal Drug Segment by Type
Prescription Drug
OTC
Botanical and Herbal Drug Segment by Application
Respiratory System
Cardiovascular
Tumor
Other
Botanical and Herbal Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical and Herbal Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Botanical and Herbal Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical and Herbal Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Botanical and Herbal Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Botanical and Herbal Drug industry.
Chapter 3: Detailed analysis of Botanical and Herbal Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical and Herbal Drugrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription Drug
- OTC
Applications
- Respiratory System
- Cardiovascular
- Tumor
- Other
Companies covered
- China TCM
- Yunnan Baiyao
- Tong Ren Tang
- Kwangdong
- Guangzhou Baiyunshan Pharmaceutical
- Weleda
- Tsumura
- Tasly Holding Group
- Taiji
- Schwabe
- Jumpcan Pharmaceutical
- Huarun 999
- GW Pharmaceuticals
- Buchang Pharmaceuticals
- Bionorica Se
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Botanical and Herbal Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Prescription Drug
- 1.2.3 OTC
- 1.3 Market Analysis by Application
- 1.3.1 Global Botanical and Herbal Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Respiratory System
- 1.3.3 Cardiovascular
- 1.3.4 Tumor
- 1.3.5 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Botanical and Herbal Drug Growth Trends by Region
- 1.5.1 Global Botanical and Herbal Drug Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Botanical and Herbal Drug Market Size by Region (2021-2026)
- 1.5.3 Botanical and Herbal Drug Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Botanical and Herbal Drug Market Dynamics
- 2.1 Botanical and Herbal Drug Industry Trends
- 2.2 Botanical and Herbal Drug Industry Drivers
- 2.3 Botanical and Herbal Drug Industry Opportunities and Challenges
- 2.4 Botanical and Herbal Drug Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Botanical and Herbal Drug Revenue by Company (2021-2026)
- 3.2 Global Botanical and Herbal Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Botanical and Herbal Drug Key Company Head office and Area Served
- 3.4 Global Botanical and Herbal Drug Company, Product Type & Application
- 3.5 Global Botanical and Herbal Drug Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Botanical and Herbal Drug Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Botanical and Herbal Drug Players Market Share by Revenue in 2025
- 3.6.3 2025 Botanical and Herbal Drug Tier 1, Tier 2, and Tier 3
4 Botanical and Herbal Drug Market by Type
- 4.1 Global Botanical and Herbal Drug Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Botanical and Herbal Drug Market Size by Type (2021-2032)
- 4.3 Global Botanical and Herbal Drug Market Size Share by Type (2021-2032)
5 Botanical and Herbal Drug Market by Application
- 5.1 Global Botanical and Herbal Drug Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Botanical and Herbal Drug Market Size by Application (2021-2032)
- 5.3 Global Botanical and Herbal Drug Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 China TCM
- 6.1.1 China TCM Company Information
- 6.1.2 China TCM Business Overview
- 6.1.3 China TCM Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 China TCM Botanical and Herbal Drug Product Portfolio
- 6.1.5 China TCM Recent Developments
- 6.2 Yunnan Baiyao
- 6.2.1 Yunnan Baiyao Company Information
- 6.2.2 Yunnan Baiyao Business Overview
- 6.2.3 Yunnan Baiyao Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Yunnan Baiyao Botanical and Herbal Drug Product Portfolio
- 6.2.5 Yunnan Baiyao Recent Developments
- 6.3 Tong Ren Tang
- 6.3.1 Tong Ren Tang Company Information
- 6.3.2 Tong Ren Tang Business Overview
- 6.3.3 Tong Ren Tang Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Tong Ren Tang Botanical and Herbal Drug Product Portfolio
- 6.3.5 Tong Ren Tang Recent Developments
- 6.4 Kwangdong
- 6.4.1 Kwangdong Company Information
- 6.4.2 Kwangdong Business Overview
- 6.4.3 Kwangdong Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Kwangdong Botanical and Herbal Drug Product Portfolio
- 6.4.5 Kwangdong Recent Developments
- 6.5 Guangzhou Baiyunshan Pharmaceutical
- 6.5.1 Guangzhou Baiyunshan Pharmaceutical Company Information
- 6.5.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
- 6.5.3 Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Product Portfolio
- 6.5.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
- 6.6 Weleda
- 6.6.1 Weleda Company Information
- 6.6.2 Weleda Business Overview
- 6.6.3 Weleda Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Weleda Botanical and Herbal Drug Product Portfolio
- 6.6.5 Weleda Recent Developments
- 6.7 Tsumura
- 6.7.1 Tsumura Company Information
- 6.7.2 Tsumura Business Overview
- 6.7.3 Tsumura Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Tsumura Botanical and Herbal Drug Product Portfolio
- 6.7.5 Tsumura Recent Developments
- 6.8 Tasly Holding Group
- 6.8.1 Tasly Holding Group Company Information
- 6.8.2 Tasly Holding Group Business Overview
- 6.8.3 Tasly Holding Group Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Tasly Holding Group Botanical and Herbal Drug Product Portfolio
- 6.8.5 Tasly Holding Group Recent Developments
- 6.9 Taiji
- 6.9.1 Taiji Company Information
- 6.9.2 Taiji Business Overview
- 6.9.3 Taiji Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Taiji Botanical and Herbal Drug Product Portfolio
- 6.9.5 Taiji Recent Developments
- 6.10 Schwabe
- 6.10.1 Schwabe Company Information
- 6.10.2 Schwabe Business Overview
- 6.10.3 Schwabe Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Schwabe Botanical and Herbal Drug Product Portfolio
- 6.10.5 Schwabe Recent Developments
- 6.11 Jumpcan Pharmaceutical
- 6.11.1 Jumpcan Pharmaceutical Company Information
- 6.11.2 Jumpcan Pharmaceutical Business Overview
- 6.11.3 Jumpcan Pharmaceutical Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Jumpcan Pharmaceutical Botanical and Herbal Drug Product Portfolio
- 6.11.5 Jumpcan Pharmaceutical Recent Developments
- 6.12 Huarun 999
- 6.12.1 Huarun 999 Company Information
- 6.12.2 Huarun 999 Business Overview
- 6.12.3 Huarun 999 Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Huarun 999 Botanical and Herbal Drug Product Portfolio
- 6.12.5 Huarun 999 Recent Developments
- 6.13 GW Pharmaceuticals
- 6.13.1 GW Pharmaceuticals Company Information
- 6.13.2 GW Pharmaceuticals Business Overview
- 6.13.3 GW Pharmaceuticals Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 GW Pharmaceuticals Botanical and Herbal Drug Product Portfolio
- 6.13.5 GW Pharmaceuticals Recent Developments
- 6.14 Buchang Pharmaceuticals
- 6.14.1 Buchang Pharmaceuticals Company Information
- 6.14.2 Buchang Pharmaceuticals Business Overview
- 6.14.3 Buchang Pharmaceuticals Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Buchang Pharmaceuticals Botanical and Herbal Drug Product Portfolio
- 6.14.5 Buchang Pharmaceuticals Recent Developments
- 6.15 Bionorica Se
- 6.15.1 Bionorica Se Company Information
- 6.15.2 Bionorica Se Business Overview
- 6.15.3 Bionorica Se Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Bionorica Se Botanical and Herbal Drug Product Portfolio
- 6.15.5 Bionorica Se Recent Developments
7 North America
- 7.1 North America Botanical and Herbal Drug Market Size (2021-2032)
- 7.2 North America Botanical and Herbal Drug Market Size by Type
- 7.2.1 North America Botanical and Herbal Drug Market Size by Type (2021-2026)
- 7.2.2 North America Botanical and Herbal Drug Market Size by Type (2027-2032)
- 7.2.3 North America Botanical and Herbal Drug Market Share by Type (2021-2032)
- 7.3 North America Botanical and Herbal Drug Market Size by Application
- 7.3.1 North America Botanical and Herbal Drug Market Size by Application (2021-2026)
- 7.3.2 North America Botanical and Herbal Drug Market Size by Application (2027-2032)
- 7.3.3 North America Botanical and Herbal Drug Market Share by Application (2021-2032)
- 7.4 North America Botanical and Herbal Drug Market Size by Country
- 7.4.1 North America Botanical and Herbal Drug Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Botanical and Herbal Drug Market Size by Country (2021-2026)
- 7.4.3 North America Botanical and Herbal Drug Market Size by Country (2027-2032)
- 7.4.4 North America Botanical and Herbal Drug Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Botanical and Herbal Drug Market Size (2021-2032)
- 8.2 Europe Botanical and Herbal Drug Market Size by Type
- 8.2.1 Europe Botanical and Herbal Drug Market Size by Type (2021-2026)
- 8.2.2 Europe Botanical and Herbal Drug Market Size by Type (2027-2032)
- 8.2.3 Europe Botanical and Herbal Drug Market Share by Type (2021-2032)
- 8.3 Europe Botanical and Herbal Drug Market Size by Application
- 8.3.1 Europe Botanical and Herbal Drug Market Size by Application (2021-2026)
- 8.3.2 Europe Botanical and Herbal Drug Market Size by Application (2027-2032)
- 8.3.3 Europe Botanical and Herbal Drug Market Share by Application (2021-2032)
- 8.4 Europe Botanical and Herbal Drug Market Size by Country
- 8.4.1 Europe Botanical and Herbal Drug Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Botanical and Herbal Drug Market Size by Country (2021-2026)
- 8.4.3 Europe Botanical and Herbal Drug Market Size by Country (2027-2032)
- 8.4.4 Europe Botanical and Herbal Drug Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Botanical and Herbal Drug Market Size (2021-2032)
- 9.2 China Botanical and Herbal Drug Market Size by Type
- 9.2.1 China Botanical and Herbal Drug Market Size by Type (2021-2026)
- 9.2.2 China Botanical and Herbal Drug Market Size by Type (2027-2032)
- 9.2.3 China Botanical and Herbal Drug Market Share by Type (2021-2032)
- 9.3 China Botanical and Herbal Drug Market Size by Application
- 9.3.1 China Botanical and Herbal Drug Market Size by Application (2021-2026)
- 9.3.2 China Botanical and Herbal Drug Market Size by Application (2027-2032)
- 9.3.3 China Botanical and Herbal Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Botanical and Herbal Drug Market Size (2021-2032)
- 10.2 Asia Botanical and Herbal Drug Market Size by Type
- 10.2.1 Asia Botanical and Herbal Drug Market Size by Type (2021-2026)
- 10.2.2 Asia Botanical and Herbal Drug Market Size by Type (2027-2032)
- 10.2.3 Asia Botanical and Herbal Drug Market Share by Type (2021-2032)
- 10.3 Asia Botanical and Herbal Drug Market Size by Application
- 10.3.1 Asia Botanical and Herbal Drug Market Size by Application (2021-2026)
- 10.3.2 Asia Botanical and Herbal Drug Market Size by Application (2027-2032)
- 10.3.3 Asia Botanical and Herbal Drug Market Share by Application (2021-2032)
- 10.4 Asia Botanical and Herbal Drug Market Size by Country
- 10.4.1 Asia Botanical and Herbal Drug Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Botanical and Herbal Drug Market Size by Country (2021-2026)
- 10.4.3 Asia Botanical and Herbal Drug Market Size by Country (2027-2032)
- 10.4.4 Asia Botanical and Herbal Drug Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Botanical and Herbal Drug Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Botanical and Herbal Drug Market Size by Type
- 11.2.1 South America, Middle East & Africa Botanical and Herbal Drug Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Botanical and Herbal Drug Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Botanical and Herbal Drug Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Botanical and Herbal Drug Market Size by Application
- 11.3.1 South America, Middle East & Africa Botanical and Herbal Drug Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Botanical and Herbal Drug Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Botanical and Herbal Drug Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Botanical and Herbal Drug Market Size by Country
- 11.4.1 South America, Middle East & Africa Botanical and Herbal Drug Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Botanical and Herbal Drug Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Botanical and Herbal Drug Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Botanical and Herbal Drug Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst